Search

everythinglearnresearchcommunity

for

Search:↓

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

GPIGS peptide increases thick hair growth in balding Japanese men.

Piperonylic acid may help hair growth and treat hair loss.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Photothermal biomodulated PRP extends hair graft viability by 2 hours compared to standard solutions.

Linear lichen planopilaris can affect the trunk, not just the face.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

The document concludes that dermal papilla cells are key for hair growth and could be used in new hair loss treatments.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

IPL treatment can significantly reduce hair in faun tail but may need local anesthesia.

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

The girl's scalp infection healed well with terbinafine treatment.

The new topical growth hormone formula has high skin penetration and bioavailability.

PHAT may improve hair growth better than PRP alone.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Regulatory measures are needed to ensure safe production and use of platelet concentrates in Brazil.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

A woman's hair loss looked like a different condition due to her hairstyle, and treatment stopped further hair loss but didn't regrow hair.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.